3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
Carboplatin
17
Filgrastim
16
Ifosfamide
13
Etoposide
13
Paclitaxel
11
Peripheral Blood Stem Cell Transplantation
10
Cisplatin
6
Thiotepa
5
Therapeutics
5
Cyclophosphamide
5
Temozolomide
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Granulocyte Colony-Stimulating Factor
4
Flow Cytometry
4
Bleomycin
4
Taxes
3
Radiotherapy
3
Methylprednisolone
3
Magnetic Resonance Spectroscopy
3
Amplified Fragment Length Polymorphism Analysis
3
Amifostine
3
sargramostim
2
pegfilgrastim
2
liposomal amphotericin B
2
ixabepilone
2
etoposide phosphate
2
aldesleukin
2
aflibercept
2
Trastuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Neoplasms
×
trastuzumab deruxtecan
×
Gynecologic
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled